Abstract:Background: To understand cartilage oligomeric matrix protein (COMP) mechanism network from human normal adjacent tissues to lung adenocarcinoma.Methods:COMPcomplete different activated (all no positive correlation, Pearson CC< 0.25) and uncomplete (partly no positive correlation exceptCOMP, Pearson CC< 0.25) network were identified in higher lung adenocarcinoma compared with lower human normal adjacent tissues from the correspondingCOMP-stimulated (≥0.25) or inhibited (Pearson CC≤−0.25) overlapping molecules of Pearson correlation coefficient (CC) and GRNInfer, respectively.COMPcomplete different activated and inhibited (all no positive correlation, Pearson CC< 0.25) mechanisms networks of higher lung adenocarcinoma and lower human normal adjacent tissues were constructed by integration of Pearson CC, GRNInfer and GO. As visualized by integration of GO, KEGG, GenMAPP, BioCarta and Disease, we deduced COMP complete different activated and inhibited network in higher lung adenocarcinoma and lower human normal adjacent tissues.Results: As visualized by GO, KEGG, GenMAPP, BioCarta and disease database integration, we proposed mainly that the mechanism and function ofCOMPcomplete different activated network in higher lung adenocarcinoma was involved inCOMPactivation with matrix-localized insulin-like factor coupling carboxypeptidase to metallopeptidase-induced proteolysis, whereas the corresponding inhibited network in lower human normal adjacent tissues participated inCOMPinhibition with nucleus-localized vasculogenesis, B and T cell differentiation and neural endocrine factors coupling pyrophosphatase-mediated proteolysis. However,COMPcomplete different inhibited network in higher lung adenocarcinoma includedCOMPinhibition with nucleus-localized chromatin maintenance, licensing and assembly factors coupling phosphatase-inhibitor to cytokinesis regulators-mediated cell differentiation, whereas the corresponding activated network in lower human normal adjacent tissues containedCOMPactivation with cytolplasm-localized translation elongation factor coupling fucosyltransferase to ubiquitinprotein ligase-induced cell differentiation.Conclusion:COMPdifferent networks were verified not only by complete and uncompleteCOMPactivated or inhibited networks within human normal adjacent tissues or lung adenocarcinoma, but also byCOMPactivated and inhibited network between human normal adjacent tissues and lung adenocarcinoma.

Hypoxia decrease expression of cartilage oligomeric matrix protein to promote phenotype switching of pulmonary arterial smooth muscle cells

Serum Cartilage Oligomeric Matrix Protein is Decreased in Patients with Pulmonary Hypertension: a Potential Protective Factor

Effects of Cartilage Oligomeric Matrix Protein on Bone Morphogenetic Protein‐2‐induced Differentiation of Mesenchymal Stem Cells

Loss of M6a Demethylase ALKBH5 Alleviates Hypoxia-Induced Pulmonary Arterial Hypertension Via Inhibiting Cyp1a1 Mrna Decay

Involvement of CapG in Proliferation and Apoptosis of Pulmonary Arterial Smooth Muscle Cells and in Hypoxia-Induced Pulmonary Hypertension Rat Model

Capping Protein Gelsolin-Like As A Therapeutic Target to Prevent Hypoxic Pulmonary Hypertension

Cartilage oligomeric matrix protein prevents vascular aging and vascular smooth muscle cells senescence

Cartilage Oligomeric Matrix Protein Maintains the Contractile Phenotype of Vascular Smooth Muscle Cells by Interacting with Α 7 Β 1 Integrin

Cartilage oligomeric matrix protein fine-tunes disturbed flow-induced endothelial activation and atherogenesis

COMP (Cartilage Oligomeric Matrix Protein), a Novel PIEZO1 Regulator That Controls Blood Pressure

Cartilage Oligomeric Matrix Protein Inhibits Vascular Smooth Muscle Calcification by Interacting with Bone Morphogenetic Protein-2.

Human pulmonary artery smooth muscle cell dysfunction is regulated by miR-509-5p in hypoxic environment

Shift of Macrophage Phenotype Due to Cartilage Oligomeric Matrix Protein Deficiency Drives Atherosclerotic Calcification

Deficiency of cartilage oligomeric matrix protein causes dilated cardiomyopathy

Cartilage Oligomeric Matrix Protein (Comp)-Mediated Cell Differentiation to Proteolysis Mechanism Networks from Human Normal Adjacent Tissues to Lung Adenocarcinoma

SOCS5, targeted by miR-155-5p, plays a negative regulatory role in pulmonary hypertension through inhibiting JAK2/STAT3 signaling pathway

Hypoxia-activated platelets stimulate proliferation and migration of pulmonary arterial smooth muscle cells by phosphatidylserine/LOX-1 signaling-impelled intercellular communication

Loss of Prolyl Hydroxylase 1 and 2 in SM22α-Expressing Cells Prevents Hypoxia-Induced Pulmonary Hypertension.

Cartilage oligomeric matrix protein participates in the pathogenesis of liver fibrosis

Cartilage oligomeric matrix protein is a novel notch ligand driving embryonic stem cell differentiation towards the smooth muscle lineage.

COMP-prohibitin 2 interaction maintains mitochondrial homeostasis and controls smooth muscle cell identity